Haven

Investors

Building the infrastructure layer for resilient medical product supply.

Haven combines regulated workflow software, supplier intelligence, official data-source review, and a staged operating strategy for a market shaped by shortages, opacity, and supply-chain fragility.

Qualified institutionsSupplier evidenceDossier workflowMilestone payments

A Large, Underserved Market

$1.2 trillion

Global pharmaceutical market, before adjacent medical supplies and devices

300%+

Increase in reported drug shortages over the past decade across North American healthcare systems

Multiple

Product classes affected by medical supply, device, diagnostic, and medicinal product bottlenecks

Healthcare supply is fragmented across medicinal products, devices, supplies, logistics, quality systems, and regulatory evidence. Haven is building the technology and operating network to make those workflows reviewable and repeatable.

Regulated products Haven supports

A broader exchange than medicines alone.

Product scope spans medicinal products, medical supplies, devices, and critical inventory where review, evidence, and logistics matter.

Surgical supplies product category

Surgical supplies

Medical devices product category

Medical devices

Medicinal products product category

Medicinal products

Cold-chain products product category

Cold-chain products

Critical consumables product category

Critical consumables

Thirty-Year Infrastructure Roadmap

1

Digital Exchange and Market Validation

Active ✓

Build the website and marketplace infrastructure, onboard suppliers and healthcare buyers, and validate demand for medical products, medicinal products, and critical supplies.

2

Regulatory, Quality, and Logistics Infrastructure

Add stronger regulatory support, vendor qualification, documentation workflows, quality assurance, logistics coordination, and data systems for demand and supplier performance.

3

Canadian Operating Infrastructure

Establish warehousing, cold-chain capabilities, packaging workflows, quality-control operations, and distribution partnerships before entering manufacturing directly.

4

Regional Medical Manufacturing Campuses

Develop AI-enabled regional health manufacturing infrastructure that may include sterile manufacturing, oral solid dose production, biologics, diagnostics, medical devices, packaging, laboratories, and automated distribution.

5

Global Medical Manufacturing Network

Replicate the campus model across regions with digital twins, AI operations, continuous manufacturing where appropriate, and standardized compliance systems.

Decision Gate Criteria

Before advancing to the next phase, Haven's leadership evaluates whether demand is proven, suppliers and documentation can be qualified, regulatory and quality pathways are clear, the economics work after landed cost, and the process can be repeated under appropriate governance.

Future GTA Flagship Campus Concept

Haven's long-term Canadian strategy includes the development of a regional health manufacturing campus in the Greater Toronto Area, with Milton, Ontario identified as a strong candidate corridor because of logistics access, industrial land base, Highway 401 connectivity, proximity to Toronto Pearson, and long-term expansion potential. This is a strategic site concept, not an acquired property or active construction project.

Why Haven Wins

01

Technology-driven medical product exchange

02

Vendor and buyer network development

03

Regulatory and quality documentation workflows

04

Data, AI, and business intelligence systems

05

Logistics, distribution, and operating infrastructure

06

Long-term vertical integration strategy

Interested in Haven's Growth Story?